Gyros Protein Technologies (Gyros AB Merged With Protein Technologies)
Dag Hammarskjolds väg 54
Uppsala Science Park
55 articles with Gyros Protein Technologies (Gyros AB Merged With Protein Technologies)
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer.
Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.
Gyros Protein Technologies and Cygnus Technologies Expand Collaboration to Support Improved Bioprocess Impurity Analytics, and Introduce HEK 293 HCP Assay Reagent Set for Gyrolab
Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform
Gyros Protein Technologies Introduces Gyrolab AAVX Titer Kit to Support Cell and Gene Therapy Market
Ready-to-use kit enables rapid adeno-associated virus titer determinations during the manufacture of AAV vectors
Mesa Laboratories, Inc., a diversified supplier of quality control instruments and consumables to highly regulated markets announced the acquisition of Gyros Protein Technologies Holding AB
9/12/2019Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines.
Ready-to-use kit enables lentivirus titer determinations during the manufacture of lentivirus vectors
9/5/2019Companies from across Europe and Asia share updates on their business and pipelines.
Flexible, modular system, designed for 21CFR Part 11 compliance
Gyros Protein Technologies Introduces Gyrolab CHO-HCP E3G Kit for Impurity Testing of Biotherapeutics
Gyros Protein Technologies AB today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls).
Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents
Gyros Protein Technologies Introduces Gyrolab xPand to Improve Immunoassay Workflow, Flexibility and Speed in Biotherapeutic Discovery, Development and Production
New 5 CD platform combines Gyrolab immunoassay technology with expanded software to optimize time to results and sample capacity while simplifying workflows; Gyrolab xPand will be showcased on March 19-22 at BPI West in San Francisco and April 9-13 at WRIB in Philadelphia
The new Gyrolab Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore systems.
Gyros Protein Technologies Signs Distribution Agreement With Luxembourg Bio Technologies For Peptide Synthesis Reagents